Dr. Boman Nariman Dhabhar – Medical Oncologist in Mumbai

Dr. Boman Nariman Dhabhar is the Director of Oncology at Fortis Hospital, Mulund, Mumbai. He is an experienced Medical Oncologist with specialised training in Medical Oncology and Hemato-Oncology. His clinical work focuses on the medical management of cancer through appropriate systemic treatments, multidisciplinary evaluation and supportive care.

Dr. Dhabhar completed his MD in Internal Medicine from the University of Mumbai before pursuing advanced oncology training at Tata Memorial Hospital, Mumbai. His professional training also includes fellowship and certification experience associated with the European Society for Medical Oncology, MD Anderson Cancer Center in the United States and Fred Hutchinson Cancer Research Center.

His clinical expertise includes the medical management of cancer, with a background in both solid tumours and haematological malignancies. Medical oncology treatment may involve chemotherapy, immunotherapy, targeted medicines and other systemic anticancer approaches selected according to the patient's cancer type, stage and clinical condition.

Dr. Boman Nariman Dhabhar is also associated with advanced cancer treatment planning and supportive oncology care. His clinical approach considers medical history, pathology findings, diagnostic imaging and relevant investigations when developing treatment strategies. Treatment may involve coordination with surgical oncologists, radiation oncologists and other specialists.

His professional affiliation with the European Society for Medical Oncology and experience at internationally recognised cancer centres reflect his specialist training in oncology. His work focuses on evidence-based cancer care, treatment assessment and the management of complex oncological conditions.

Patients seeking a Medical Oncologist in Mumbai for cancer diagnosis review, chemotherapy, immunotherapy or other systemic cancer treatments can consult Dr. Boman Nariman Dhabhar at Fortis Hospital, Mulund. The availability of specific treatments and consultation appointments should be confirmed with the hospital.

Medical Oncology Consultation

Medical oncology consultation involves evaluating cancer diagnoses, reviewing pathology and imaging reports, and determining whether systemic cancer treatment is appropriate. The oncologist considers cancer type, stage, molecular findings and the patient's overall health before discussing potential treatment options and their expected benefits and risks.

Chemotherapy Treatment

Chemotherapy uses anticancer medicines to destroy or inhibit the growth of cancer cells. It may be administered intravenously or orally, depending on the diagnosis and treatment plan. Patients require monitoring for treatment response, blood counts and possible side effects throughout therapy.

Cancer Immunotherapy

Immunotherapy uses medicines that help the immune system recognise or respond to certain cancers. Suitability depends on cancer type, disease stage and relevant biomarker findings. Treatment requires monitoring because immune-related adverse effects may affect the lungs, liver, digestive system and other organs.

Targeted Cancer Therapy

Targeted cancer therapy uses medicines directed toward specific proteins or molecular pathways involved in tumour growth. Certain treatments require genetic or biomarker testing before they can be prescribed. The choice of medicine depends on the cancer diagnosis, previous treatments and patient characteristics.

Hemato-Oncology Assessment

Hemato-oncology focuses on cancers affecting blood-forming tissues and the lymphatic system. Evaluation may involve blood tests, bone marrow investigations, imaging and specialised pathology. Management depends on the specific disease and may require systemic medicines, supportive treatment or assessment for advanced therapies.

Blood Cancer Management

Blood cancers include conditions such as leukaemia, lymphoma and multiple myeloma. Treatment varies significantly according to the disease subtype and clinical findings. Management can involve chemotherapy, targeted therapy, immunotherapy or referral for specialised cellular and transplant-based treatment where appropriate.

Solid Tumour Management

Solid tumours are malignancies that develop in organs or other body tissues. Medical treatment depends on tumour location, cancer stage and molecular characteristics. An oncologist may coordinate chemotherapy, immunotherapy or targeted medicines alongside surgical and radiation oncology teams.

Stem Cell Transplantation Assessment

Stem cell transplantation may be considered for selected blood cancers and other haematological conditions. Assessment involves reviewing disease characteristics, treatment history, donor or collection options and medical fitness. Transplant procedures require specialist infrastructure, infection prevention and careful long-term monitoring.

Biological Cancer Therapy

Biological cancer treatments use medicines that interact with specific biological pathways or immune processes involved in cancer. Some treatments target tumour proteins, while others influence immune activity. The appropriate approach depends on the diagnosis, biomarker findings and available clinical evidence.

Cancer Treatment Response Monitoring

Monitoring during cancer treatment helps determine whether therapy is controlling disease and whether adverse effects are occurring. Evaluation may include clinical examination, blood investigations and imaging. Results guide decisions about continuing, modifying or changing the prescribed treatment regimen.

Supportive Oncology Care

Supportive oncology care addresses symptoms and treatment-related problems such as nausea, fatigue, reduced appetite and infection risk. Management may involve supportive medicines, nutrition advice and coordination with other specialists. The goal is to help patients tolerate treatment and maintain daily functioning.

Multidisciplinary Cancer Treatment Planning

Multidisciplinary cancer treatment planning brings together specialists such as medical oncologists, surgeons, radiation oncologists, radiologists and pathologists. The team considers the diagnosis, disease stage and treatment options to develop a coordinated approach suited to the patient's medical needs.